G. David Roodman MD PhD
Kenneth Wiseman Professor of Medicine, Director of Hematology Oncology, Co-leader of the Hematopoiesis, Hematologic Malignancy and Immunology Program for the IU Simon Cancer Center, IU School of Medicine
Dr. Roodman was recruited to IUSM in 2011 to direct the Hematology Oncology Division in the Dept. of Medicine. Dr. Roodman previously was Vice Chair of Medicine for Research at University of Pittsburgh and the University of Texas Health Science Center at San Antonio. Dr. Roodman’s research interests focus on how cell-cell interactions among hematopoietic cells and cells in the bone marrow microenvironment control normal and malignant hematopoiesis and diseases affecting bone remodeling. Currently, his laboratory is involved in studies of the pathogenesis and progression of Paget's Disease and myeloma bone disease, and how cell-cell interactions between osteoclast and osteoblast precursors, and other cells in the marrow microenvironment lead to increased bone remodeling in Paget’s Disease, and the enhanced osteoclastogenesis and suppressed bone formation that contribute to myeloma cell growth and chemoresistance. Dr. Roodman has authored more than 350 peer reviewed publication and book chapters and is a member of the ASCI, AAP and a Fellow of the AAAS. He is currently president of the Cancer and Bone Society. His laboratory has been continuously funded by the NIH and VA Merit Review Program since 1981.